- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
7
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
7 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥27.1b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥58.34
7D
-8.8%
1Y
-21.3%
PharmaResources (Shanghai)
Market Cap: CN¥4.7b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥26.13
7D
-23.9%
1Y
-9.6%
AcrobiosystemsLtd
Market Cap: CN¥8.8b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥52.60
7D
-2.1%
1Y
-2.8%
Xiamen Amoytop Biotech
Market Cap: CN¥24.1b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.08
7D
-2.0%
1Y
-22.5%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥8.9b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥24.40
7D
-5.6%
1Y
-28.9%
Inner Mongolia Furui Medical Science
Market Cap: CN¥12.1b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥45.85
7D
6.9%
1Y
9.2%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥6.6b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥12.23
7D
-17.1%
1Y
-26.8%